☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
App
Advertisement
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Injection
Jazz's Vyxeos (daunorubicin and cytarabine liposome) for Injection Receives Health Canada Approval for the Treatment of High-risk...
July 9, 2021
Jazz's Vyxeos (daunorubicin and cytarabine liposome) for Injection Receives Health Canada Approval for the Treatment of High-risk...
July 9, 2021
Innovent's Tyvyt (sintilimab) + Byvasda (biosimilar- bevacizumab) Receive the NMPA's Approval as 1L Therapy for Hepatocellular Car...
June 29, 2021
Innovent's Tyvyt (sintilimab) + Byvasda (biosimilar- bevacizumab) Receive the NMPA's Approval as 1L Therapy for Hepatocellular Car...
June 29, 2021
Lantheus' Pylarify (piflufolastat F 18) Injection Receives the US FDA's Approval for the Treatment of Prostate Cancer
May 27, 2021
Lantheus' Pylarify (piflufolastat F 18) Injection Receives the US FDA's Approval for the Treatment of Prostate Cancer
May 27, 2021
Load more...
Back to Home